Skip to main content
. 2017 Sep 11;5(10):e992–e1003. doi: 10.1016/S2214-109X(17)30298-X

Table.

Prevalence of anti-hepatitis D virus and hepatitis D virus RNA in HBsAg-positive general populations and liver disease populations in sub-Saharan Africa, 1995–2015

Year Population Tested (n) Anti-hepatitis D virus positive
Hepatitis D virus RNA positive*
n (%) 95% CI n (%) 95% CI
General populations
West Africa
Benin21 2011 Pregnant women 44 5 (11%) 5–24 ·· ··
Burkina Faso31 2015 Blood donors 177 6 (3%) 1–7 ·· ··
Burkina Faso18 2001 Mothers 40 1 (3%) 0–14 0 (0) 0–83
The Gambia34 2013 Community members 394 8 (2%) 1–4 ·· ··
The Gambia34 2013 Blood donors 292 1 (<1%) 0–2 ·· ··
Ghana33 2015 Community members 107 9 (8%) 4–15 ·· ··
Ghana 2010 Patients from HIV clinics 222 5 (2%) 1–5 2 (40%) 12–77
Guinea-Bissau23 2011 Patients from HIV clinics 72 18 (25%) 16–36 4 (44%)§ 19–73
Mauritania25 2008 Blood donors 447 90 (20%) 17–24 56 (62%) 52–72
Mauritania26 2008–09 Pregnant women 109 16 (15%) 9–23 11 (69%) 44–86
Mauritania26 2008–09 Medical outpatients 162 31 (19%) 14–26 21 (68%) 50–82
Nigeria32 2014 Medical outpatients 103 5 (5%) 2–11 ·· ··
Nigeria18 2004 Patients from HIV clinics 45 3 (7%) 2–19 2 (67%) 20–94
Nigeria18 1998 Patients from HIV clinics 11 3 (27%) 9–57 0 (0) 0–62
Senegal30 2003 Blood donors 175 5 (3%) 1–7 ·· ··
Senegal22 1998–2002 Patients from HIV clinics 61 2 (3%) 0–12 ·· ··
Central Africa
Cameroon42 2011 National survey participants 1627 225 (14%) 12–15 ·· ··
Cameroon36 2011 Health-care workers 17 6 (35%) 17–59 ·· ··
Cameroon41 2010 Patients from HIV clinics 25 3 (12%) 3–31 1 (33%) 6–80
Cameroon37 2007 Pregnant women 259 19 (7%) 5–11 ·· ··
Gabon43 2015 Community members|| 74 33 (45%) 33–56 ·· ··
Gabon39 2005 Pregnant women 109 17 (16%) 10–24 ·· ··
Gabon40 2008 Community members|| 124 82 (66%) 57–74 ·· ··
East or southern Africa
Botswana44 2006–08 Pregnant women 9 0 (0) 0–35 ·· ··
Malawi 2007–09 Patients from HIV clinics 133 2 (2%) 0–6 0 (0) 0–71
Mozambique45 2007 Blood donors 146 0 (0) 0–3 ·· ··
South Africa19 2008 Pregnant women 87 0 (0) 0–5 ·· ··
South Africa44 2008 HIV-positive pregnant or postnatal women 45 0 (0) 0–9 ·· ··
South Africa44 2004–10 Pregnant women 6 0 (0) 0–44 ·· ··
Tanzania46 2013–14 Patients from HIV clinics 219 11 (5%) 3–9 0 (0) 0–30
Liver disease populations
West Africa
Ghana20 2014 Patients from hepatology clinics 53 6 (11%) 5–23 ·· ··
Mauritania24 2009 Patients from hepatology clinics 296 98 (33%) 28–39 61 (62%) 52–71
Nigeria28 2012 Patients with HCC 26 0 (0) 0–15 ·· ··
Nigeria29 2009–10 Patients from hepatology clinics (15% had cirrhosis, 3% had HCC) 245 5 (2%) 1–5 ·· ··
Nigeria47 2006 Patients from hepatology clinics (22% had cirrhosis, 51% had HCC) 96 12 (13%) 1–21 ·· ··
Nigeria18 2006 Patients from hepatology clinics 78 1 (1%) 0–8 1 (100%) 17–100
Nigeria18 2003 Patients from hepatology clinics 44 3 (7%) 2–19 0 (0) 0–62
Senegal30 2003 Patients from hepatology clinics 29 4 (14%) 5–31 ·· ··
Senegal27 1995 Patients from hepatology clinics (39% had cirrhosis, 57% had HCC) 54 13 (24%) 15–37 ·· ··
Central Africa
Cameroon38 2008–09 Patients from hepatology clinics 233 41 (18%) 13–23 25 (61%) 42–74
Central African Republic18 2009 Patients from hepatology clinics 14 7 (50%) 27–73 5 (71%) 35–92
Central African Republic35 2006–09 Patients with HCC 69 36 (52%) 41–64 ·· ··

HCC=hepatocellular carcinoma.

*

Percentages are calculated in the group of patients who are anti-hepatitis D virus positive.

Study was done in a rural setting.

Data are from the present study.

§

Only nine of 18 samples were tested for hepatitis D virus RNA.

The study population was attendees at a general (non-hepatology) medical clinic without known liver disease.

||

Cluster-sampling community survey.